Janumet and Nitrostat drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Janumet (metformin hydrochloride; sitagliptin phosphate) and Nitrostat (nitroglycerin). Common drug interactions include hospitalisation among females and drug ineffective among males.

The phase IV clinical study analyzes what interactions people have when they take Janumet and Nitrostat. It is created by eHealthMe based on reports of 74 people who take the same drugs from the FDA, and is updated regularly.

What is Janumet?

Janumet has active ingredients of metformin hydrochloride; sitagliptin phosphate. It is often used in diabetes. eHealthMe is studying from 25,023 Janumet users. Check the latest studies of Janumet.

What is Nitrostat?

Nitrostat has active ingredients of nitroglycerin. It is often used in chest pain. eHealthMe is studying from 14,082 Nitrostat users. Check the latest studies of Nitrostat.



On Jul, 10, 2026

74 people who take Janumet and Nitrostat together, and have interactions are studied.

Janumet and Nitrostat drug interactions.

What are the common drug interactions of Janumet and Nitrostat, by gender? *:

female:

  1. Hospitalisation
  2. Hypophagia (reduced food intake)
  3. Middle ear effusion (fluid in middle ear)
  4. Nail disorder (disease of nail)
  5. Neuropathy peripheral (surface nerve damage)
  6. Orthostatic hypotension (a medical condition consisting of a sudden decrease in blood pressure when a person stands up)
  7. Renal injury (kidney injury)
  8. Renal tubular necrosis (death of kidney tubules)
  9. Vision blurred
  10. Visual impairment

male:

  1. Drug ineffective
  2. Chronic kidney disease
  3. Urinary tract infection
  4. Acute myocardial infarction (acute heart attack)
  5. Albumin urine present
  6. Cardiac failure congestive
  7. Cellulitis (infection under the skin)
  8. Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)
  9. Creatinine renal clearance decreased
  10. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)

What are the common drug interactions of Janumet and Nitrostat, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Arterial occlusive disease (slow process through which arteries throughout the body become progressively narrowed and eventually completely blocked)
  2. Arthralgia (joint pain)
  3. Bone pain
  4. Cellulitis (infection under the skin)
  5. Chronic kidney disease
  6. Contusion (a type of hematoma of tissue in which capillaries)
  7. Diarrhoea
  8. Dizziness
  9. Drug hypersensitivity
  10. Dyskinesia (abnormality or impairment of voluntary movement)

50-59:

  1. Anaesthetic complication
  2. Colorectal cancer (colon cancer or bowel cancer)
  3. Haematuria (presence of blood in urine)
  4. Chronic kidney disease
  5. Renal failure (kidney dysfunction)
  6. Albumin urine present
  7. Creatinine renal clearance decreased
  8. Glomerular filtration rate decreased
  9. Haematochezia (passage of stools containing blood)
  10. Haemoptysis (blood-stained sputum from the bronchi, larynx, trachea, or lungs)

60+:

  1. Chronic kidney disease
  2. Fall
  3. Pneumonia
  4. Renal injury (kidney injury)
  5. Staphylococcal infection (an infection with staphylococcus bacteria)
  6. Subdural haematoma (blood collects between the skull and the surface of the brain)
  7. Urinary tract infection
  8. Cardiac enzymes increased
  9. Cardiac valve disease (heart valve disease)
  10. Drug effect delayed

What are the existing conditions these people have? *

  1. High Blood Pressure: 36 people, 48.65%
  2. High Blood Cholesterol: 30 people, 40.54%
  3. Pain: 25 people, 33.78%
  4. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 24 people, 32.43%
  5. Stable Angina (a constant chest pain): 22 people, 29.73%
  6. Cardiac Disorder: 22 people, 29.73%
  7. Depression: 21 people, 28.38%
  8. Nausea (feeling of having an urge to vomit): 20 people, 27.03%
  9. Stress And Anxiety: 18 people, 24.32%
  10. Constipation: 17 people, 22.97%

* Approximation only. Some reports may have incomplete information.

Do you take Janumet and Nitrostat?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Janumet and Nitrostat:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Janumet:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Nitrostat:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Janumet and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Nitrostat and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on metformin hydrochloride; sitagliptin phosphate and nitroglycerin (the active ingredients of Janumet and Nitrostat, respectively), and Janumet and Nitrostat (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: